Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notice Inventory
  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed within each year since 1998, when FDA received its first GRAS notice. Once FDA has responded to a GRAS notice, the text of FDA's response will also be available as part of the record for that notice. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.

Records shown on this page: This page is a partial listing of all records in the database. Additional pages/records are available for selection at the bottom of the page. To view all records in the database select the All button at the bottom of the page. To search for a specific food ingredient, enter the term in the Search Criteria box and select Show Items to display only those records that contain the selected term. To view the text of the agency's response to the GRAS notice, select the text in the FDA's Letter column describing the response. Select the specific GRN number in the GRN No. column to view additional detail about any GRAS notice, including in some cases the submission itself. The agency has removed nondisclosable information from these submissions. All copyrighted information has also been removed and the bibliographic information listed in a reference table at the end of the submission.





     No of Records Found:  465
GRN No.
(select GRN No. for detailed record)		 Substance FDA's Letter
(select to view letter)
315 Transglucosidase enzyme preparation from Trichoderma reesei expressing the gene encoding transglucosidase from Aspergillus niger FDA has no questions
314 Pork protein FDA has no questions
313 Beef protein FDA has no questions
312 Synthetic dihydrocapsiate FDA has no questions
311 Krill-based phosphatidylserine FDA has no questions; some uses may require a color additive listing
310 Potato fiber FDA has no questions
309 Beta-glucan derived from Aureobasidium pullulans FDA has no questions
308 L-leucine FDA has no questions
307 Palm oil-derived tocols with tocotrienols and α-tocopherol as the principal components FDA has no questions; some uses may require a color additive listing
306 Soybean oil with reduced palmitic and linolenic acids and increased oleic acid FDA has no questions
305 Carnobacterium maltaromaticum strain CB1 (viable and heat-treated) FDA has no questions
304 Purified steviol glycosides with rebaudioside A and stevioside as the principal components FDA has no questions
303 Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni FDA has no questions
302 1,3-propanediol FDA has no questions
301 Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract (SGFE) FDA has no questions
300 Trisodium diphosphate FDA has no questions
299 Lycopene from Escherichia coli expressing lycopene biosynthetic enzymes At notifier's request, FDA ceased to evaluate the notice
298 Silicon dioxide At notifier's request, FDA ceased to evaluate the notice
297 Erythritol fatty acid esters FDA has no questions
296 Lipase enzyme preparation from a genetically modified strain of Aspergillus niger FDA has no questions
295 Aqueous extract of Emblica officinalis At notifier's request, FDA ceased to evaluate the notice
294 Haematococcus pluvialis extract containing astaxanthin esters FDA has no questions; some uses may require a color additive listing
293 Glutathione FDA has no questions
292 Cellulase enzyme preparation derived from a genetically modified strain of Myceliophthora thermophila FDA has no questions
291 Crystalline lutein FDA has no questions
290 L-arginine FDA has no questions
289 Colicin E1 purified from Escherichia coli At notifier's request, FDA ceased to evaluate the notice
288 Lactobacillus rhamnosus strain HN001 FDA has no questions
287 Purified steviol glycosides with rebaudioside A and stevioside as the principal components FDA has no questions
286 Galacto-oligosaccharides FDA has no questions
285 Galacto-oligosaccharides FDA has no questions
284 Bakers yeast mannoprotein FDA has no questions
283 Stearidonic acid soybean oil FDA has no questions
282 Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni FDA has no questions
281 Lactobacillus rhamnosus strain HN001 produced in a milk-based medium FDA has no questions
280 Whole and milled flaxseed FDA has no questions
279 Phosphatidylserine derived from fish FDA has no questions
278 Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni FDA has no questions
277 Maltotetraohydrolase enzyme preparation from Bacillus licheniformis expressing a modified maltotetraohydrolase gene from Pseudomonas stutzeri FDA has no questions
276 Dunaliella bardawil alga At notifier's request, FDA ceased to evaluate the notice
275 Purified steviol glycosides with rebaudioside A as the principal component FDA has no questions
274 Branching glycosyltransferase enzyme preparation from Bacillus subtilis expressing a branching glycosyltransferase gene from Rhodothermus obamensis FDA has no questions
273 Baobab (Adansonia digitata) dried fruit pulp FDA has no questions
272 Triple salt of magnesium, ammonium, and potassium chloride, hexahydrate FDA has no questions
271 Ferrous ammonium phosphate FDA has no questions
270 Polyglycerol polyricinoleic acid FDA has no questions
269 Polyglycerol fatty acid esters with a degree of polymerization of 11 to 40 for the polyglycerol backbone FDA has no questions
268 Bifidobacterium longum strain BB536 FDA has no questions
267 Protein glutaminase enzyme preparation derived from Chryseobacterium proteolyticum FDA has no questions
266 Polyglycerol polyricinoleate FDA has no questions

Prev  |  Next  |  1  |  2  |  3  |  [4]  |  5  |  First  |  Last  |  All

-
-